HomeHAVLF • OTCMKTS
add
HAVN Life Sciences Inc
Previous close
$0.0010
Market cap
859.38K CAD
Avg Volume
68.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 276.47K | — |
Operating expense | 8.07M | -58.47% |
Net income | -22.44M | 26.13% |
Net profit margin | -8.12K | — |
Earnings per share | — | — |
EBITDA | -7.50M | 49.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.06M | -88.77% |
Total assets | 4.06M | -71.49% |
Total liabilities | 918.46K | -11.72% |
Total equity | 3.14M | — |
Shares outstanding | 5.79M | — |
Price to book | 0.00 | — |
Return on assets | -54.49% | — |
Return on capital | -58.02% | — |
Cash Flow
Net change in cash
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Net income | -22.44M | 26.13% |
Cash from operations | -7.88M | 24.44% |
Cash from investing | -2.03M | -411.91% |
Cash from financing | 1.56M | -91.62% |
Net change in cash | -8.35M | -207.21% |
Free cash flow | -3.17M | -256.55% |
About
CEO
Founded
2020
Headquarters
Website
Employees
6
